- Zacks•7 hours ago
MedTech Long-Term Prospects Impress: Which Stocks to Buy?
- TheStreet.com•10 hours ago
Abbott Laboratories appears poised to enjoy a fruitful year, though its litigation with former takeover target Alere could hold it back.
- PR Newswire•16 hours ago
ABBOTT PARK, Ill., March 22, 2017 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2017 financial results on Wednesday, April 19, 2017, before the market opens. The announcement will ...
ABT : Summary for Abbott Laboratories Common Stoc - Yahoo Finance
Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||44.59 - 45.07|
|52 Week Range||36.76 - 45.84|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||47.82|
|Dividend & Yield||1.06 (2.36%)|
|1y Target Est||N/A|